🚀 VC round data is live in beta, check it out!
Farmacosmo Valuation Multiples
Discover revenue and EBITDA valuation multiples for Farmacosmo and similar public comparables like Matvareexpressen, Sosandar, SC Ropharma, Laxus Technologies and more.
Farmacosmo Overview
About Farmacosmo
Farmacosmo SpA is a wellness e-commerce company active in the Health, Pharma, and Wellness industry, authorized by the Italian Ministry of Health to sell pharmaceutical products online. In particular, the company offers parapharmaceutical products, vitamins and food supplements, dietetic products, medical devices, cosmetic products, personal hygiene products, hair care products, dental care products, skincare products, perfumes, home and baby items.
Founded
2013
HQ
Employees
N/A
Website
Financials (FY)
EV
$25M
Farmacosmo Financials
Farmacosmo reported last fiscal year revenue of $73M and EBITDA of $840K.
In the same fiscal year, Farmacosmo generated $19M in gross profit, $840K in EBITDA, and had net loss of ($3M).
Farmacosmo P&L
In the most recent fiscal year, Farmacosmo reported revenue of $73M and EBITDA of $840K.
Farmacosmo expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $73M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $19M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 26% | XXX | XXX | XXX |
| EBITDA | — | XXX | $840K | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 1% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (3%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($3M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (5%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Farmacosmo Stock Performance
Farmacosmo has current market cap of $23M, and enterprise value of $25M.
Market Cap Evolution
Farmacosmo's stock price is $0.59.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $25M | $23M | 0.3% | XXX | XXX | XXX | $-0.09 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialFarmacosmo Valuation Multiples
Farmacosmo trades at 0.3x EV/Revenue multiple, and 29.8x EV/EBITDA.
Farmacosmo Financial Valuation Multiples
As of March 19, 2026, Farmacosmo has market cap of $23M and EV of $25M.
Equity research analysts estimate Farmacosmo's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Farmacosmo has a P/E ratio of (6.7x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $23M | XXX | $23M | XXX | XXX | XXX |
| EV (current) | $25M | XXX | $25M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 0.3x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 29.8x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (10.6x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 1.3x | XXX | XXX | XXX |
| P/E | — | XXX | (6.7x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (6.5x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Farmacosmo Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Farmacosmo Margins & Growth Rates
Farmacosmo's revenue in the last fiscal year declined by (11%).
Farmacosmo Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (11%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 1% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (280%) | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 30% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Farmacosmo Public Comps
See public comps and valuation multiples for other Consumer E-commerce and Pharmacies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Matvareexpressen | XXX | XXX | XXX | XXX | XXX | XXX |
| Sosandar | XXX | XXX | XXX | XXX | XXX | XXX |
| SC Ropharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Laxus Technologies | XXX | XXX | XXX | XXX | XXX | XXX |
| Wellgistics Health | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Farmacosmo M&A Activity
Farmacosmo acquired XXX companies to date.
Last acquisition by Farmacosmo was on XXXXXXXX, XXXXX. Farmacosmo acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Farmacosmo
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialFarmacosmo Investment Activity
Farmacosmo invested in XXX companies to date.
Farmacosmo made its latest investment on XXXXXXXX, XXXXX. Farmacosmo invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Farmacosmo
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Farmacosmo
| When was Farmacosmo founded? | Farmacosmo was founded in 2013. |
| Where is Farmacosmo headquartered? | Farmacosmo is headquartered in Italy. |
| Is Farmacosmo publicly listed? | Yes, Farmacosmo is a public company listed on Borsa Italiana. |
| What is the stock symbol of Farmacosmo? | Farmacosmo trades under COSMO ticker. |
| When did Farmacosmo go public? | Farmacosmo went public in 2022. |
| Who are competitors of Farmacosmo? | Farmacosmo main competitors are Matvareexpressen, Sosandar, SC Ropharma, Laxus Technologies. |
| What is the current market cap of Farmacosmo? | Farmacosmo's current market cap is $23M. |
| What is the current revenue of Farmacosmo? | Farmacosmo's last fiscal year revenue is $73M. |
| What is the current EV/Revenue multiple of Farmacosmo? | Current revenue multiple of Farmacosmo is 0.3x. |
| Is Farmacosmo profitable? | No, Farmacosmo is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.